We are live on ! Find out more
BIM

Baldwin Investment Management Portfolio holdings

AUM $1.03B
1-Year Est. Return 22.29%
This Fund
S&P 500
This Quarter Est. Return
+8.44%
1 Year Est. Return
+22.29%
3 Year Est. Return
+74.82%
5 Year Est. Return
+112.14%
10 Year Est. Return
+391.06%
AUM
$587M
AUM Growth
+$39.6M
Cap. Flow
-$3.74M
Cap. Flow %
-0.64%
Top 10 Hldgs %
52.18%
Holding
263
New
21
Increased
74
Reduced
116
Closed
11

Sector Composition

Rank Sector Weight
1 Financials 50.02%
2 Technology 13.64%
3 Healthcare 8.61%
4 Industrials 5.66%
5 Consumer Discretionary 5.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.A icon
1
Berkshire Hathaway Class A
BRK.A
$1.11T
$240M 40.9%
574
-3
-0.5% -$1.26M
AAPL icon
2
Apple
AAPL
$4.85T
$12.7M 2.16%
92,706
-4,035
-4% -$523K
MSFT icon
3
Microsoft
MSFT
$3.64T
$11.4M 1.94%
42,065
-882
-2% -$224K
JPM icon
4
JPMorgan Chase
JPM
$927B
$8.19M 1.39%
52,682
-501
-0.9% -$78.7K
LRCX icon
5
Lam Research
LRCX
$337B
$6.72M 1.14%
103,210
+1,150
+1% +$72.6K
AMZN icon
6
Amazon
AMZN
$2.65T
$5.71M 0.97%
33,220
+1,080
+3% +$179K
V icon
7
Visa
V
$693B
$5.66M 0.96%
24,206
+75
+0.3% +$17.1K
BLK icon
8
Blackrock
BLK
$161B
$5.53M 0.94%
6,323
-160
-2% -$135K
JNJ icon
9
Johnson & Johnson
JNJ
$644B
$5.32M 0.91%
32,288
-1,050
-3% -$174K
BMY icon
10
Bristol-Myers Squibb
BMY
$130B
$5.02M 0.85%
75,071
+2,848
+4% +$186K
ABBV icon
11
AbbVie
ABBV
$464B
$4.96M 0.84%
44,043
-324
-0.7% -$36.5K
BRK.B icon
12
Berkshire Hathaway Class B
BRK.B
$1.11T
$4.77M 0.81%
17,157
-387
-2% -$108K
NKE icon
13
Nike
NKE
$53.1B
$4.7M 0.8%
30,434
-60
-0.2% -$8.07K
AVGO icon
14
Broadcom
AVGO
$1.62T
$4.62M 0.79%
96,800
+2,380
+3% +$110K
EPD icon
15
Enterprise Products Partners
EPD
$82.3B
$4.61M 0.78%
190,936
+5,570
+3% +$132K
SBUX icon
16
Starbucks
SBUX
$111B
$4.59M 0.78%
41,066
+134
+0.3% +$15.1K
ZTS icon
17
Zoetis
ZTS
$30.2B
$4.57M 0.78%
24,533
+155
+0.6% +$26.9K
ADBE icon
18
Adobe
ADBE
$99.6B
$4.37M 0.74%
7,463
+35
+0.5% +$18K
COST icon
19
Costco
COST
$396B
$4.35M 0.74%
10,986
-35
-0.3% -$13.2K
TMO icon
20
Thermo Fisher Scientific
TMO
$240B
$4.29M 0.73%
8,507
+357
+4% +$168K
ABT icon
21
Abbott
ABT
$177B
$4.26M 0.73%
36,784
+456
+1% +$53.2K
NVDA icon
22
NVIDIA
NVDA
$5.17T
$4.21M 0.72%
210,520
-8,920
-4% -$143K
MTD icon
23
Mettler-Toledo International
MTD
$27.6B
$4.17M 0.71%
3,009
-16
-0.5% -$20.6K
GS icon
24
Goldman Sachs
GS
$273B
$3.99M 0.68%
10,506
-228
-2% -$81.6K
FISV
25
Fiserv Inc
FISV
$26.3B
$3.98M 0.68%
37,241
-2,017
-5% -$234K

Similar funds

Baldwin Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, Baldwin Investment Management held 263 positions worth $587M, up 7.2% from $548M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Baldwin Investment Management's Q2 2021 filing shows 21 new, 74 increased, 116 reduced and 11 closed positions. Its largest new stake was Comcast: 47,851 shares worth $2.73M. The largest sale was Berkshire Hathaway Class A, an estimated $1.26M.

By sector, the portfolio is most concentrated in Financials at 50% of assets, up from 49% a quarter earlier, followed by Technology and Healthcare.

  • Baldwin Investment Management's largest Q2 2021 buy was Comcast: 47,851 shares worth $2.73M.
  • Baldwin Investment Management added most to Skyworks Solutions in Q2 2021, an estimated $485K increase.
  • Baldwin Investment Management's biggest Q2 2021 reduction was Berkshire Hathaway Class A, cutting an estimated $1.26M.
  • Baldwin Investment Management fully exited Immunome in Q2 2021, selling an estimated $860K.
  • Baldwin Investment Management's ten largest holdings make up 52% of its $587M portfolio in Q2 2021.
  • Baldwin Investment Management opened 21 new positions and closed 11 in Q2 2021.
  • Baldwin Investment Management's portfolio value rose 7.2% quarter-over-quarter to $587M.

Based on Baldwin Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.